Effect of VR on Anxiety and Pain in Gynecological Surgery (VRAP-G)
Pain, Postoperative, Anxiety, Pain Catastrophizing
About this trial
This is an interventional treatment trial for Pain, Postoperative focused on measuring Postoperative pain, Anxiety, State anxiety, Pain catastrophizing, Analgesic use
Eligibility Criteria
Inclusion Criteria:
- Written and orally given informed consent
- 18 years and older
- Native Dutch speaker
- Indication for elective gynecological surgery under spinal anesthesia
- No contra-indication to anesthesia:
Exclusion Criteria:
- Chronic pain patients; defined as 'persistent or recurrent pain lasting longer than 3 months' . The pain is not due to the gynecological problem.
- Chronical use of pain medication (opioids)
- History of prior opioid use defined as use within 8 to 90 days prior to the surgical procedure
- Alcohol or drug abuse
- Known car sickness
- Epileptic insults in previous history
- Psychotically seizures in previous history
- Claustrophobic
- Blindness
- History of mental illness
Sites / Locations
- Zuyderland Medical Centre
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
VR-group
Standard care-group
The participants randomised into this group can choose for an immersive guided relaxation VR experience or an interactive VR experience. The VR intervention is additional to the standard postoperative care management, the standard pain protocol is explained below. The VR-intervention will be given using the Oculus Go Virtual Reality glasses with touchpad.
The participants randomized into the standard care- group will receive the usual standard pre-and postoperative management. Standard pain protocol: Preoperative (arrival day-care unit) start with 1000mg paracetamol orally administered. Postoperative Meloxicam 15mg orally administered, or when oral medication is not possible (due to nausea e.g.) than diclofenac supp 100mg or diclofenac i.v. 75mg. On recovery ward, when necessary depending on pain score (NRS>4): dipidolor 2.5-5mg i.v. and 10-15mg i.m. after consulting the anesthesiologist. Postoperative at home 4dd1000mg paracetamol will be continued, in combination with meloxicam 1dd15mg during 3 days. Also tramadol 50mg with a maximum of 4dd will be prescribed.